home / stock / apyx / apyx news


APYX News and Press, Apyx Medical Corporation

Stock Information

Company Name: Apyx Medical Corporation
Stock Symbol: APYX
Market: NASDAQ
Website: apyxmedical.com

Menu

APYX APYX Quote APYX Short APYX News APYX Articles APYX Message Board
Get APYX Alerts

News, Short Squeeze, Breakout and More Instantly...

APYX - Apyx Medical Corporation Launches the "Renewing Lives" Give-Back Campaign Providing Treatments with Renuvion to Benefit Physical Appearance and Mental Health

Apyx Medical Corporation Launches the "Renewing Lives" Give-Back Campaign Providing Treatments with Renuvion to Benefit Physical Appearance and Mental Health PR Newswire Renuvion is the only device FDA-cleared for contracting subcutaneous tissue CLEARWATER, Fla. ...

APYX - APYX Stock Earnings: Apyx Medical Misses EPS, Beats Revenue for Q1 2024

2024-05-09 11:57:38 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Apyx Medical (NASDAQ: APYX ) just reported results for the first quarter of 2024. Apyx Medical reported earnings per share of -22 cents. This was below the analyst estimat...

APYX - Apyx Medical GAAP EPS of -$0.22 in-line, revenue of $10.2M beats by $0.67M

2024-05-09 08:21:09 ET More on Apyx Medical Apyx Medical Corporation (APYX) Q4 2023 Earnings Call Transcript Apyx Medical reports mixed Q4 results; initiates FY24 outlook Seeking Alpha’s Quant Rating on Apyx Medical Historical earnings data for Apyx Me...

APYX - Apyx Medical Corporation Reports First Quarter 2024 Financial Results; Reaffirms Full Year 2024 Financial Outlook

Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion ® , today reported financial results for its first quarter ended March 31, 202...

APYX - Expected US Company Earnings on Thursday, May 9th, 2024

AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...

APYX - Apyx Medical Corporation Announces Board Leadership Transition

Andrew Makrides Retiring Following More Than 40 Years of Service as Chairman of the Board of Directors; Stavros Vizirgianakis Appointed to Succeed Mr. Makrides as Chairman Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical”; the “Company”),...

APYX - Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion ® , today announced that financial results for the first quarter of fiscal year 2024 will be released before...

APYX - Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users' Summit

Shaping the Future of Aesthetic Treatments with Advanced Medical Technology Apyx® Medical Corporation (NASDAQ:APYX) (the “Apyx Medical”; “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvi...

APYX - APYX Stock Earnings: Apyx Medical Misses EPS, Misses Revenue for Q4 2023

2024-03-21 11:53:48 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Apyx Medical (NASDAQ: APYX ) just reported results for the fourth quarter of 2023. Apyx Medical reported earnings per share of -28 cents. This was below the analyst estima...

APYX - PHIO and MGRM among healthcare movers

2024-03-21 10:12:15 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Johnson & Johnson, Boston Scientific least shorted stocks in S&...

Next 10